Global Intravenous Immunoglobulin (IVIg) Market Growth 2025-2031

Global Intravenous Immunoglobulin (IVIg) Market Growth 2025-2031

The global Intravenous Immunoglobulin (IVIg) market size is predicted to grow from US$ 11300 million in 2025 to US$ 16140 million in 2031; it is expected to grow at a CAGR of 6.1% from 2025 to 2031.

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.

Global Intravenous Immunoglobulin (IVIg) main players are Baxter, Grifols, CSL, Octapharma, etc. Global top four manufacturers hold a share above 65%. North America is the largest market, with a share about 45%.

LP Information, Inc. (LPI) ' newest research report, the “Intravenous Immunoglobulin (IVIg) Industry Forecast” looks at past sales and reviews total world Intravenous Immunoglobulin (IVIg) sales in 2024, providing a comprehensive analysis by region and market sector of projected Intravenous Immunoglobulin (IVIg) sales for 2025 through 2031. With Intravenous Immunoglobulin (IVIg) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intravenous Immunoglobulin (IVIg) industry.

This Insight Report provides a comprehensive analysis of the global Intravenous Immunoglobulin (IVIg) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intravenous Immunoglobulin (IVIg) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Intravenous Immunoglobulin (IVIg) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intravenous Immunoglobulin (IVIg) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intravenous Immunoglobulin (IVIg).

This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Immunoglobulin (IVIg) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
IVIg Liquid
IVIg Powder

Segmentation by Application:
Immunodeficiency
Autoimmune Disease
Acute Infection

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang

Key Questions Addressed in this Report

What is the 10-year outlook for the global Intravenous Immunoglobulin (IVIg) market?

What factors are driving Intravenous Immunoglobulin (IVIg) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Intravenous Immunoglobulin (IVIg) market opportunities vary by end market size?

How does Intravenous Immunoglobulin (IVIg) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.